Cold-EEZE Claims Chilled By Zicam Maker’s NAD Challenge
This article was originally published in The Tan Sheet
Executive Summary
NAD says ProPhase should alter claims about how much Cold-EEZE reduces the duration of colds, in a decision on a case brought by competitor Matrixx Initiatives. The advertising watchdog group calls for tweaks to a number of ProPhase’s claims.